Looking for a Low-Risk Trade? You Need to See This

He quit his job as a high-powered attorney at the age of 37 and became a million-dollar trader. Now -- for the first time -- he's sharing his biggest secret... one he calls "profit windows." Discover how this simple 'trick' pinpoints trades for you that deliver gains of 116%... 137%... and even 227%... In weeks (NOT years).

Vertex Pharma scientist talks about the long road to developing non-addictive painkillers

MATTHEW PERRONE
April 15, 2024

WASHINGTON (AP) -- For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.

Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country's ongoing drug epidemic.

Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn't meet a secondary goal of outperforming treatment with an opioid.

The Associated Press spoke with Vertex's chief scientist Dr. David Altshuler about the company's research and development plans. The interview has been edited for length and clarity.

Q: Why is Vertex interested in new drugs for treating pain?

There is a great need for additional medicines to help people manage pain. There are medicines like Tylenol that are modestly effective but they're very well tolerated. And there's medicines such as opioids that are very effective but unfortunately have side effects, as well as addictive potential.

Identifying additional medicines that could be used for people who need more pain relief but don't want to take the risks of opioids would be helpful for society.

Q: How did you develop these drugs?

Vertex has been working on this for 20 years, and the insight that led to the medicines actually came from studies of people who had a rare condition where they are insensitive to pain. They can feel things, sense temperature, but do not feel pain. This was actually identified in a family of fire walkers who could walk on hot coals.

So scientists figured out that that condition was due to inherited differences in a particular protein that has a role in pain signaling-- so if you lack this function you don't feel pain. So we and many others have worked for decades to make a medicine that could recapitulate that naturally-occurring phenomenon.

Q: Why wouldn't these drugs carry the same addictive properties as opioids?

Addictive medicines typically work in the brain and they have side effects that aren't really separable from the reduction in pain, because they're the same thing. That's their mechanism of action. In our case, our goal is to make medicines that act in the periphery, not in the brain, so they wouldn't have the same potential risk.

Q: Tell me about the recent data you've reported?

We've reported three studies in people with acute pain -- things like surgery or an injury -- all three studies were positive, all three studies showed substantial reduction of pain of about 50%.

One of the secondary endpoints was superiority to the opioid and the drugs were not superior to the opioid that was used for comparison, they were similar in magnitude. But because opioids have so many safety and tolerability issues, a medicine that could have similar efficacy but does not have those challenges might be of interest to people in pain.

Q: Are you testing this approach in patients with long-term pain?

We also did a study of diabetic peripheral neuropathy, which is long-term pain caused when people with diabetes have damaged nerves. That was also a positive study that showed clinically meaningful reduction in pain. So based on that study, a phase 2 study, we're now planning for a phase 3 study.

Q: What comes next?

For acute pain we're preparing to file for FDA approval based on our data. For the longer-term pain, what's called neuropathic pain, it's earlier in the development stage but the data is encouraging so far. So we're continuing studies to determine if it's possible to apply for approval there.

Continue Reading...

Popular

Top 3 Utilities Stocks That May Rocket Higher This Month

The most oversold stocks in the utilities sector presents an opportunity to buy into undervalued companies.

Nvidia faces a reckoning as an upstart rival raises questions about Wall Street's darling

NEW YORK (AP) — The superstar run for Nvidia’s stock the last few years has been astonishing. So was its tumble Monday, which caused $595 billion in wealth to vanish. That’s about as much as PepsiCo, McDonalds, Starbucks and Target are worth, combined.

Consistent Profits Every Day - Ad

LitePips EA delivers steady profits with no risky strategies like Grid, Arbitrage, Scalping or Hedge. Enjoy stable trading with fixed Stop Loss and Take Profit, over 62% WinRate, DrawDown below 32% and 100%+ annual returns. Not forget about tools like spread filters, slippage protection, and equity safeguards, it's the perfect choice for XAUUSD H1 traders.

Dubai's ceaseless boom is putting strains on its residents

DUBAI, United Arab Emirates (AP) — — and some residents are starting to feel burned.

Tesla Likely To Sell Optimus To Rivals In 2026, Elon Musk Says Revenue Potential Of Bot North Of $10 Trillion: 'It's Real Bananas'

Tesla Inc CEO Elon Musk on Wednesday said that the company intends to make several thousand units of its Optimus humanoid robot this year for deployment in its own factory which will inform the next version of the robot slated for launch next year and likely to be sold to rival companies.

Struggling to Get By? This Could Be a Godsend - Ad

If you knew with 90% certainty, Amazon was about to tack on 22.5% to its share price... AND you also knew exactly when that climb would start and end... how much money do you think you'd be able to rake in? $1,000... $5,000... $25,000... Maybe even more? If you'll give me 5 minutes... I'd like to help you answer that question.

China's factory activity contracts in January for the first time in 4 months

HONG KONG (AP) — Manufacturing slowed in China in January for the first time in four months as workers began leaving assembly lines to travel to their hometowns for Lunar New Year holidays.

NASA's 2 stuck astronauts take their first spacewalk together

CAPE CANAVERAL, Fla. (AP) — NASA’s took their first spacewalk together Thursday, exiting the International Space Station almost eight months after moving in.

Three Companies Could Benefit Greatly From AI's Next Boom This Year - Ad

My 2025 AI Blueprint features three of what I call Nvidia's "Silent Partners." Some of the world's hottest companies are working with AI's undisputed leader, Nvidia. And I've identified three of them that appear to be well-positioned for the next AI boom in 2025. Everything you need to know about them in my 2025 AI Blueprint.

Did DeepSeek copy ChatGPT? Trump adviser thinks so

Did the upstart copy ChatGPT to make the artificial intelligence technology that this week?

Magnificent 7 Earnings Ahead: 3 ETFs To Ride The Wave

Earnings season in full swing, attention on tech giants known as Magnificent 7: 3 ETFs to consider.

Warren Buffett's Investing Partner's Shocking Final Move - Ad

Before he passed away, Charlie Munger, Warren Buffett's investing partner of 60 years, was rumored to have quietly made one final investment... Up until now, it has remained hidden from the public. It's potentially the smartest, most profitable, and most under-valued AI investment you can make today.

Tesla, Meta, Microsoft, IBM, Nvidia: Why These 5 Stocks Are On Investors' Radars Today

On Wednesday, January 29, 2025, TSLA, META, MSFT, IBM, NVDA were among the stocks that dominated investor attention on the day Federal Reserve chose to keep the interest rates steady.

Stryker's Strategic Moves Impress Analysts, Spine Implant Sale and NARI Deal Set to Drive Future Growth

Wall Street analysts upgraded Stryker Corp (NYSE: SYK) after its Q4 report beat expectations, with strong sales and earnings growth projected for 2025.

Legendary Tech Investor: "Forget Nvidia, Buy This Instead" - Ad

In February 2016, Jeff Brown picked Nvidia as one of his favorite stocks. Since then, shares have jumped enough to turn $1,000 into more than $230,000. If you missed out on those massive gains...

Kansas City Battles Major Tuberculosis Outbreak, 67 Active Cases, Hundreds Under Watch

Kansas City faces one of the worst U.S. tuberculosis outbreaks, with 67 active cases and 384 people under monitoring.

3 AI Stocks Tied to President Trump's White House Return - Ad

Trump's return to the White House coincides with AI's -- and Nvidia's -- continued boom. That's why the President is crucial to Michael Robinson's 2025 AI Blueprint. Michael is a 40-year veteran of Silicon Valley has an AI Blueprint featuring three companies working with Nvidia who could be poised to benefit now that Trump is back in the White House.

F5 Sees Big Wins in Multi-Cloud, AI Security, and IT Refresh, Analysts Forecast More Upside

F5 Inc (NASDAQ: FFIV) reported strong Q1 results, beating revenue and EPS estimates. The stock gained as analysts raised price targets and expectations for further growth from IT budgets, data center refresh, and AI demand.

Unlocking a Polymetallic Discovery Like No Other - Ad

With drill results rivaling the best in the world and a fully funded 2025 program, this polymetallic stock is poised for major growth. Industry icons Robert Friedland and Rob McEwen are already in. Will you be next?

Trump Slams Fed's 'Terrible Job' On Bank Regulation After Rate Hold, Vows To 'Unleash Lending For All American People'

President Donald Trump criticized the Federal Reserve's handling of inflation and banking regulation on Wednesday, following the central bank's decision to hold interest rates steady at 4.25%-4.5%.

Apple Surprises Users With Starlink Beta, Teams Up With Elon Musk's SpaceX And T-Mobile To Bring Satellite Texting For iPhone Users In iOS 18.3

Apple has partnered with SpaceX and T-Mobile to bring Starlink satellite texting to iPhones, with a limited beta test rolling out via iOS 18.3, marking a major step toward expanding connectivity in remote areas.

The Closest Thing to 'Push Button' Investing - Ad

You buy when these 'windows' open -- and sell when they close... Yes, it's that easy. It doesn't matter if you're just starting out, or if you've been investing for decades... This brain-dead simple trading strategy is designed to deliver triple-digit gains - WITHOUT tying your money up for years on end.

Mark Zuckerberg Says China's DeepSeek Did Some Novel Things 'We're Still Digesting,' But Meta May Keep Pouring Billions Into AI Infrastructure Anyway

Meta CEO Mark Zuckerberg acknowledged that China's DeepSeek made novel advancements that Meta is still evaluating but emphasized that the company will continue investing billions in AI infrastructure, seeing it as a long-term strategic advantage.

Dan Ives Expects Meta And Microsoft To Stand Firm On $60 - $80 Billion AI Spending Plans Amid DeepSeek's Disruptive AI Model

Wedbush Securities analyst Dan Ives expects Meta Platforms Inc. and Microsoft Corp. to stand firm on their ambitious artificial intelligence spending plans during their upcoming earnings calls, despite recent market jitters over Chinese AI startup DeepSeek's emergence.

Crypto Stocks Are Heating Up - Ad

At the center of this transformation is a game-changing platform that's experiencing explosive growth with $41 million in revenue in just nine months. The stock has doubled in the last 45 days, but this is only the beginning.

Nvidia Says DeepSeek An 'Illustration' Of How New AI Models Can Be Created While Being Export-Control Compliant Amid $600 Billion Market Value Plunge

Nvidia Corp. has thrown its support behind China's DeepSeek R1 artificial intelligence model, calling it "an excellent AI advancement" even as the startup's emergence triggered a historic $600 billion plunge in the chipmaker's market value on Monday.

The DOGE Agenda (Nine Stocks to Buy) - Ad

One Boston based think tank – who has studied Elon's work for decades – is stepping forward to share what they've found. They believe his TRUE plan is far more radical than anyone realizes. It could change the way you live, work, get paid...AND could make more people rich than all of Elon's previous ventures.

Elon Musk's Tesla Records $600 Million In Paper Gains On Bitcoin In Q4 Thanks To New Accounting Rule

Electric vehicle behemoth Tesla Inc. (NASDAQ:TSLA) reported an unrealized gain of $600 million on its cryptocurrency holdings in the fourth quarter.

The Next Big Opportunity in Electric Vehicles - Ad

The electric revolution is hitting the water, and one company is surging ahead with unmatched efficiency and groundbreaking tech. Positioned in a market expected to triple by 2033, This stock is making waves among smart investors.

'Mona Lisa' will get its own room under a major renovation of the Louvre

PARIS (AP) — French President Emmanuel Macron announced Tuesday that will get its own dedicated room inside the Louvre museum under a major renovation and expansion of the Paris landmark that will take up to a decade.

3 coup-hit West African nations formally leave ECOWAS in an unprecedented disintegration

ABUJA, Nigeria (AP) — The of Niger, Mali and Burkina Faso have formally withdrawn from the regional bloc known as ECOWAS, the body said Wednesday, the culmination of a yearlong process during which the group tried to avert its unprecedented disintegration.

Elon Musk's Critical Metals Warning: What Investors Need to Know - Ad

Elon Musk has repeatedly warned about the looming critical metals crisis, calling materials like nickel, copper, and PGMs essential to Tesla's future. One Canadian discovery in Quebec is drawing comparisons to Russia's Norilsk Mine and has the potential to reshape global supply chains. With heavyweight backers and a fully funded exploration plan, this opportunity demands attention.

Trains canceled across Bangladesh as rail union goes on strike

DHAKA, Bangladesh (AP) — Trains were canceled across Bangladesh on Tuesday as railway staff went on strike for higher pensions and other benefits, affecting tens of thousands of passengers and freight transport.

Czech Central Bank Considering 5% Bitcoin Reserve

The Czech National Bank (CNB) could become the first Western central bank known to allocate a portion of its reserves to Bitcoin (CRYPTO: BTC).

This Electric Boating Stock Has Potential To Soar - Ad

While competitors struggle, one company is leading the electric boating industry with scalable production, strategic partnerships, and a revolutionary powertrain. In a market set to move, this stock is quietly gaining momentum.

DeepSeek Suffers 'Degraded Performance,' Says Hit By 'Large-Scale Malicious Attacks' After Rapidly Emerging As App Store Chart Topper

Chinese AI startup DeepSeek faced significant cyberattacks amid its rapid rise, including topping the U.S. App Store and challenging AI giants with its cost-effective R1 language model.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service